B.WangC
In a small prospective proof-of-concept trial [100], authors recruited nine diabetic patients with asthma who were given the GLP-1 RA liraglutide
Melanotan II has never been approved for cosmetic tanning, and people are essentially experimenting on themselves with products that may contain unknown ingredients, inconsistent dosing, or contaminants. If Melanotan II and its cohort are taken off the restricted list, will we be seeing it sold at medspas and pharmacies, promising a safer, easier, faster tan
These medications also slow gastric emptying, which could potentially affect bowel function, though no direct link to diverticulitis flare-ups has been established
State Medicaid programs face budget pressure, so obesity-drug coverage can change quickly
Expansion of digital prescription services and licensed online pharmacies is making home delivery more accessible